Skip to content
healthcare services hero image
healthcare services hero image

Healthcare Services

Allen & Overy can provide legal services creating a solid foundation for your healthcare infrastructure projects.

Development and provision of specialised healthcare infrastructure is one of the key themes in modern times and requires specialist advice. The unique issues raised by the public service nature of hospitals, nursing homes, rehabilitation centres, clinics, academic and commercial R&D facilities always challenge investors, sponsors and lenders. As a global firm, we can successfully guide you through all stages of the lifecycle of healthcare infrastructure projects. In the healthcare infrastructure sector, we regularly advise on lettings and leasings, development, planning and construction, environmental issues and implications, private/public partnerships, including public procurement, transitional employment issues, commercial agreements with stakeholders, outsourcing, data protection and privacy, strategic licensing and collaboration agreements, global joint ventures, M&A and restructuring.

News & insights

Microscope with lights on

Blog Post: 14 JUNE 2021

Process patents – paper tigers or effective protective rights?

Thoughts on “sufficient likelihood” in the sense of section 140c German Patent Act (PatG).

Read more
Screen displaying stock information

News: 04 JUNE 2021

A&O advising Babylon on its USD4.2bn merger with special purpose acquisition company Alkuri Global

A team from Allen & Overy’s Corporate M&A practice is advising Babylon Holdings Limited (Babylon), a world leading digital-first value-based care company, on its definitive merger agreement with…

Read more

Publications: 16 OCTOBER 2020

Podcast: Meet Caroline Riady - Healthcare and leadership in turbulent times

As part of our Women’s Network series, this week on G&R Airtime we are joined by Caroline Riady, CEO of Siloam Hospitals Group which is the single largest private hospital group in Indonesia. 

Read more

Publications: 02 SEPTEMBER 2019

China: amendment to Drug Administration Law

On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.

Related expertise